Merck Says Research Shows Its COVID-19 Pill Works Against Variants
(Reuters) – Laboratory studies show that Merck & Co’s experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective […]
(Reuters) – Laboratory studies show that Merck & Co’s experimental oral COVID-19 antiviral drug, molnupiravir, is likely to be effective […] BRASILIA (Reuters) – The Pan American Health Organization (PAHO) warned on Wednesday that countries in the region could continue to […] When it comes to receiving the COVID-19 vaccine, people understandably want to do their research before making a decision, especially […] With global COVID cases declining and pandemic fatigue on the rise, many countries are easing restrictions put in place to […] (HealthDay)—Among Israeli adults aged 60 years and older, those receiving a third booster dose of the Pfizer-BioNTech COVID-19 vaccine have […] More than 1,000 schools across the country start school year with virtual learning Dr. Marty Makary of Johns Hopkins School […] MANILA (Reuters) – Scores of healthcare workers protested in the Philippine capital on Wednesday to demand an end to what […] Growing list of colleges mandate COVID-19 vaccine This fall, more than 800 universities will require students to get a COVID-19 […] As the the COVID-19 vaccination campaign continues worldwide, research is ongoing to improve the vaccines available and develop new, effective, […] A number of countries including the United States and the United Kingdom are moving to make a third dose of […]COVID-19
Merck Says Research Shows Its COVID-19 Pill Works Against Variants
Americas Health Agency Sees COVID Outbreaks Continuing Into 2022
Misinformation about COVID-19 vaccine endangering pregnant women
Turn the page on COVID-19? Not so fast, say experts
COVID-19 vaccine booster dose cuts infection in those 60 and older
COVID-19 vaccine and kids: Why can’t children under 12 receive shots yet? FDA weighs in
Philippines Health Workers Protest Neglect as COVID-19 Strains Hospitals
COVID-19 vaccinations in rural areas hit fastest pace in 6 weeks: report
COVID-19: An innovative candidate vaccine shows efficacy in preclinical models
Why is a third COVID-19 vaccine dose important for people who are immunocompromised?
Copyright © 2024